Coupling to a cancer-selective heparan-sulfate-targeted branched peptide can bypass breast cancer cell resistance to methotrexate
This technology helps the OD identify subclinical microaneurysms at the deep capillary plexus, dilations of the vessels, intraretinal microvascular abnormalities, capillary non-perfusion, vascular loops, vascular tortuosity, and neovascularization
The data from using these medications for weight loss are promising, with more studies currently being conducted for other uses like cardiovascular disease, fatty liver and substance use disorders
Safety and quality matter
Reproductive endocrinologist Dr Allison Rodgers said: Its true that, from a scientific perspective, these medications may make it easier for people to get pregnant